{"id":"https://openalex.org/W2603736070","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.7087","title":"Ruxolitinib in polycythemia vera: Follow-up from the RESPONSE trial.","display_name":"Ruxolitinib in polycythemia vera: Follow-up from the RESPONSE trial.","publication_year":2015,"publication_date":"2015-05-20","ids":{"openalex":"https://openalex.org/W2603736070","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.7087","mag":"2603736070"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2015.33.15_suppl.7087","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.7087","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.7087","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085521139","display_name":"Sr\u0111an Verstov\u0161ek","orcid":"https://orcid.org/0000-0002-6912-8569","observed_orcids":["https://orcid.org/0000-0002-6912-8569"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srdan Verstovsek","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046772202","display_name":"Alessandro Maria Vannucchi","orcid":"https://orcid.org/0000-0001-5755-0730","observed_orcids":["https://orcid.org/0000-0001-5755-0730"]},"institutions":[{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessandro M. Vannucchi","raw_affiliation_strings":["University of Florence, Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florence, Florence, Italy","institution_ids":["https://openalex.org/I45084792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006360930","display_name":"Martin Grie\u00dfhammer","orcid":"https://orcid.org/0000-0001-8718-7004","observed_orcids":["https://orcid.org/0000-0001-8718-7004"]},"institutions":[{"id":"https://openalex.org/I4210162969","display_name":"Johannes Wesling Klinikum Minden","ror":"https://ror.org/05d89kr76","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210162969"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin Griesshammer","raw_affiliation_strings":["Johannes Wesling Clinic, Minden, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johannes Wesling Clinic, Minden, Germany","institution_ids":["https://openalex.org/I4210162969"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087934925","display_name":"Tam\u00e1s Masszi","orcid":"https://orcid.org/0000-0003-2322-9863","observed_orcids":["https://orcid.org/0000-0003-2322-9863"]},"institutions":[{"id":"https://openalex.org/I4210119027","display_name":"Unified Szent Istv\u00e1n and Szent L\u00e1szl\u00f3 Hospital","ror":"https://ror.org/02gxnzq82","country_code":"HU","type":"healthcare","lineage":["https://openalex.org/I4210119027"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Tam\u00e1s Masszi","raw_affiliation_strings":["St. Istv\u00e1n and St. L\u00e1szl\u00f3 Hospital, Budapest, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Istv\u00e1n and St. L\u00e1szl\u00f3 Hospital, Budapest, Hungary","institution_ids":["https://openalex.org/I4210119027"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028552390","display_name":"Simon Durrant","orcid":"https://orcid.org/0000-0003-3659-179X","observed_orcids":["https://orcid.org/0000-0003-3659-179X"]},"institutions":[{"id":"https://openalex.org/I2799393793","display_name":"Royal Brisbane and Women's Hospital","ror":"https://ror.org/05p52kj31","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1302211766","https://openalex.org/I2799393793","https://openalex.org/I2801244131"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Simon Durrant","raw_affiliation_strings":["Royal Brisbane & Women\u2019s Hospital, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Brisbane & Women\u2019s Hospital, Brisbane, Australia","institution_ids":["https://openalex.org/I2799393793"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009381933","display_name":"Francesco Passamonti","orcid":"https://orcid.org/0000-0001-8068-5289","observed_orcids":["https://orcid.org/0000-0001-8068-5289"]},"institutions":[{"id":"https://openalex.org/I2801668426","display_name":"Ospedale di Circolo e Fondazione Macchi","ror":"https://ror.org/02s6h0431","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I2801668426"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesco Passamonti","raw_affiliation_strings":["Ospedale di Circolo e Fondazione Macchi, Varese, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ospedale di Circolo e Fondazione Macchi, Varese, Italy","institution_ids":["https://openalex.org/I2801668426"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046827092","display_name":"Claire N. Harrison","orcid":"https://orcid.org/0000-0002-3212-920X","observed_orcids":["https://orcid.org/0000-0002-3212-920X"]},"institutions":[{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Claire N. Harrison","raw_affiliation_strings":["Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom","institution_ids":["https://openalex.org/I200166805"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057084037","display_name":"Fabrizio Pane","orcid":"https://orcid.org/0000-0003-2563-4125","observed_orcids":["https://orcid.org/0000-0003-2563-4125"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Fabrizio Pane","raw_affiliation_strings":["University of Naples Federico II, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Naples Federico II, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036582191","display_name":"Pierre Zach\u00e9e","orcid":"https://orcid.org/0000-0002-2275-5143","observed_orcids":["https://orcid.org/0000-0002-2275-5143"]},"institutions":[{"id":"https://openalex.org/I4210150429","display_name":"Ziekenhuisnetwerk Antwerpen Stuivenberg","ror":"https://ror.org/05dpzfc16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210150429","https://openalex.org/I4405261247"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Pierre Zachee","raw_affiliation_strings":["ZNA Stuivenberg, Antwerp, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ZNA Stuivenberg, Antwerp, Belgium","institution_ids":["https://openalex.org/I4210150429"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001816724","display_name":"Masayuki Hino","orcid":"https://orcid.org/0000-0002-9128-7750","observed_orcids":["https://orcid.org/0000-0002-9128-7750"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masayuki Hino","raw_affiliation_strings":["Department of Clinical Hematology and Diagnostics, Osaka University Graduate School of Medicine, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Hematology and Diagnostics, Osaka University Graduate School of Medicine, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051359342","display_name":"Beatriz Moiraghi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103251","display_name":"Hospital Ramos Mej\u00eda","ror":"https://ror.org/01bnyxq20","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210103251"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Beatriz Moiraghi","raw_affiliation_strings":["Hospital Jose Maria Ramos Mejia, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Jose Maria Ramos Mejia, Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4210103251"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109288290","display_name":"Carole Brennan Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1310298795","display_name":"Saint Agnes Hospital","ror":"https://ror.org/0011azt19","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1310298795"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carole Brennan Miller","raw_affiliation_strings":["St Agnes Cancer Institute, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St Agnes Cancer Institute, Baltimore, MD","institution_ids":["https://openalex.org/I1310298795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019241495","display_name":"Vittorio Rosti","orcid":"https://orcid.org/0000-0003-4195-2289","observed_orcids":["https://orcid.org/0000-0003-4195-2289"]},"institutions":[{"id":"https://openalex.org/I4210151645","display_name":"Policlinico San Matteo Fondazione","ror":"https://ror.org/05w1q1c88","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210151645","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Vittorio Rosti","raw_affiliation_strings":["Center for the Study of Myelofibrosis, IRCCS Policlinico San Matteo Foundation, Pavia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for the Study of Myelofibrosis, IRCCS Policlinico San Matteo Foundation, Pavia, Italy","institution_ids":["https://openalex.org/I4210151645"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039057642","display_name":"Ruben A. Mesa","orcid":"https://orcid.org/0000-0001-5880-7972","observed_orcids":["https://orcid.org/0000-0001-5880-7972"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruben A. Mesa","raw_affiliation_strings":["Mayo Clinic Cancer Center, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Cancer Center, Scottsdale, AZ","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mark M. Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I924451375","display_name":"Incyte (United States)","ror":"https://ror.org/00cvzzg84","country_code":"US","type":"company","lineage":["https://openalex.org/I924451375"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark M. Jones","raw_affiliation_strings":["Incyte Corporation, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Incyte Corporation, Wilmington, DE","institution_ids":["https://openalex.org/I924451375"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Huiling Zhen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I924451375","display_name":"Incyte (United States)","ror":"https://ror.org/00cvzzg84","country_code":"US","type":"company","lineage":["https://openalex.org/I924451375"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Huiling Zhen","raw_affiliation_strings":["Incyte Corporation, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Incyte Corporation, Wilmington, DE","institution_ids":["https://openalex.org/I924451375"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103281201","display_name":"Jingjin Li","orcid":"https://orcid.org/0009-0000-3867-990X","observed_orcids":["https://orcid.org/0009-0000-3867-990X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jingjin Li","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047003547","display_name":"Nathalie Francillard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092929","display_name":"Novartis (France)","ror":"https://ror.org/00geypp27","country_code":"FR","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210092929"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nathalie Francillard","raw_affiliation_strings":["Novartis Pharma S.A.S., Rueil-Malmaison, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma S.A.S., Rueil-Malmaison, France","institution_ids":["https://openalex.org/I4210092929"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030898208","display_name":"Dany Habr","orcid":"https://orcid.org/0000-0002-3361-6309","observed_orcids":["https://orcid.org/0000-0002-3361-6309"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dany Habr","raw_affiliation_strings":["Novartis Pharmaceuticals, East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals, East Hanover, NJ","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008609620","display_name":"Jean\u2010Jacques Kiladjian","orcid":"https://orcid.org/0000-0002-8121-438X","observed_orcids":["https://orcid.org/0000-0002-8121-438X"]},"institutions":[{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]},{"id":"https://openalex.org/I4387154366","display_name":"Universit\u00e9 Paris Diderot","ror":"https://ror.org/02n7qrg46","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387154366"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Jacques Kiladjian","raw_affiliation_strings":["H\u00f4pital Saint-Louis and Paris Diderot University, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Saint-Louis and Paris Diderot University, Paris, France","institution_ids":["https://openalex.org/I4210144610","https://openalex.org/I4387154366"]}]}],"institutions":[],"countries_distinct_count":10,"institutions_distinct_count":19,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"15_suppl","first_page":"7087","last_page":"7087"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.9900000095367432},{"id":"https://openalex.org/keywords/polycythemia-vera","display_name":"polycythemia vera","score":1.0},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.6980000138282776},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.5709999799728394},{"id":"https://openalex.org/keywords/hematocrit-control","display_name":"hematocrit control","score":0.8019999861717224},{"id":"https://openalex.org/keywords/phlebotomy","display_name":"phlebotomy","score":0.7160000205039978},{"id":"https://openalex.org/keywords/spleen-volume-reduction","display_name":"spleen volume reduction","score":0.9419999718666077},{"id":"https://openalex.org/keywords/complete-hematologic-remission","display_name":"complete hematologic remission","score":0.9929999709129333},{"id":"https://openalex.org/keywords/hydroxyurea-intolerance","display_name":"hydroxyurea intolerance","score":0.722000002861023},{"id":"https://openalex.org/keywords/pruritus","display_name":"pruritus","score":0.6610000133514404},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6869999766349792},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.5609999895095825},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.5559999942779541},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.7149999737739563}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9272003173828125},{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.8066731691360474},{"id":"https://openalex.org/C2777357209","wikidata":"https://www.wikidata.org/wiki/Q3595842","display_name":"Phlebotomy","level":2,"score":0.6431972980499268},{"id":"https://openalex.org/C2778837598","wikidata":"https://www.wikidata.org/wiki/Q948318","display_name":"Polycythemia vera","level":2,"score":0.6235216856002808},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5261539816856384},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.458863228559494},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.42243972420692444},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4223736524581909},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.14919570088386536}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2015.33.15_suppl.7087","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.7087","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.7087","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2783012969","https://openalex.org/W2336835135","https://openalex.org/W2803381821","https://openalex.org/W2326125048","https://openalex.org/W2987230910","https://openalex.org/W2551573304","https://openalex.org/W2920145783","https://openalex.org/W2912061124","https://openalex.org/W3095758083","https://openalex.org/W2981576356"],"abstract_inverted_index":{"7087":[0],"Background:":[1],"The":[2,67,280,304,372],"RESPONSE":[3],"trial":[4,414],"is":[5],"a":[6,59,85,233,407],"multicenter,":[7],"open-label":[8],"phase":[9],"3":[10,159,352],"study":[11,302],"evaluating":[12],"the":[13,40,100,144,162,167,172,177,189,194,204,221,270,295,311,318,328,378],"efficacy":[14],"and":[15,84,108,340,356,361,395],"safety":[16],"of":[17,36,99,191,206,215,252,267,272,291,301,363,374,410],"ruxolitinib":[18],"(Rux)":[19],"compared":[20,139,157],"with":[21,29,401],"best":[22],"available":[23],"therapy":[24],"(BAT)":[25],"in":[26,89,171,193,250,265,294,310,359,377],"patients":[27],"(pts)":[28],"polycythemia":[30],"vera":[31],"resistant":[32],"to":[33,128,140,158,238,382],"or":[34,349,353],"intolerant":[35],"hydroxyurea.":[37],"Results":[38],"from":[39,45,213,235,368],"primary":[41,68,101,178],"analysis,":[42],"48":[43,146,164,330,370],"wks":[44,64,212,277],"last":[46],"pt":[47],"first":[48],"treatment":[49,134,375,396],"(LPFT),":[50],"were":[51,118,132,314,346,393],"published":[52],"(Vannucchi,":[53],"NEJM":[54],"2015).":[55],"Methods:":[56],"This":[57],"was":[58,70,218,248,263,278,285],"second":[60],"preplanned":[61],"analysis":[62,147,321],"80":[63,211,276,320],"after":[65],"LPFT.":[66],"response":[69,179,209,217],"defined":[71],"as":[72,113,115],"achieving":[73],"both":[74],"hematocrit":[75],"(HCT)":[76],"control":[77,200],"without":[78],"phlebotomy":[79],"(PBT)":[80],"through":[81],"wk":[82,96,145,163,181,202,227,236,246,261,319,329,369],"32":[83,237,247,262],"\u2265":[86,241],"35%":[87,242],"reduction":[88,244],"spleen":[90,105],"volume":[91,106],"(SV)":[92],"by":[93],"imaging":[94],"at":[95,143,161,180,201,226,245,260,298,317,327,406],"32.":[97],"Durability":[98],"response,":[102],"HCT":[103,199],"control,":[104],"reduction,":[107],"complete":[109],"hematologic":[110],"remission":[111],"(CHR),":[112],"well":[114,399],"long-term":[116],"safety,":[117],"evaluated.":[119],"Results:":[120],"At":[121],"data":[122],"cutoff,":[123],"91":[124],"(82.7%)":[125],"pts":[126,153,160,170,192,223,293],"randomized":[127],"Rux":[129,173,195,225,253,268,296,312,379,391,405],"(Rux":[130],"arm)":[131],"receiving":[133,404],"(median":[135,148],"exposure,":[136,149],"111":[137,411],"wks),":[138],"93":[141],"(84.5%)":[142],"81":[150],"wks).":[151],"No":[152],"remained":[154,385,397],"on":[155,224],"BAT,":[156],"analysis.":[165],"Of":[166,220],"23":[168],"(21%)":[169],"arm":[174,196,297,313,380],"who":[175,197],"achieved":[176,198,249,264],"32,":[182,203,228],"only":[183],"1":[184,348],"lost":[185],"this":[186,208],"response.":[187,258],"For":[188],"60%":[190],"probability":[205,271],"maintaining":[207,273],"for":[210,275,289],"time":[214],"initial":[216],"89%.":[219],"98":[222],"90%":[229],"did":[230],"not":[231],"have":[232],"PBT":[234],"80.":[239],"A":[240],"SV":[243],"38%":[251],"pts;":[254,269],"all":[255],"maintained":[256],"their":[257,299],"CHR":[259,274],"24%":[266],"69%.":[279],"Pruritus":[281],"Symptoms":[282],"Impact":[283],"Scale":[284],"\u201cvery":[286],"much":[287],"improved\u201d":[288],"5":[290],"10":[292],"end":[300],"visit.":[303],"most":[305,345],"common":[306],"nonhematologic":[307],"adverse":[308,383],"events":[309,384],"headache":[315],"(21.8%":[316],"[ie,":[322],"entire":[323],"follow-up]":[324],"vs":[325,334,338,343],"20.9%":[326],"analysis),":[331],"diarrhea":[332],"(20.0%":[333,337],"19.1%),":[335],"pruritus":[336],"17.3%),":[339],"fatigue":[341],"(17.3%":[342],"17.3%);":[344],"grade":[347],"2.":[350],"Grade":[351],"4":[354],"anemia":[355],"thrombocytopenia":[357],"occurred":[358],"1.8%":[360],"5.5%":[362],"pts,":[364],"respectively":[365],"(no":[366],"increase":[367],"analysis).":[371],"rate":[373],"discontinuation":[376],"due":[381],"low":[386],"(4.5%).":[387],"Conclusions:":[388],"In":[389],"RESPONSE,":[390],"responses":[392],"durable":[394],"generally":[398],"tolerated,":[400],"83%":[402],"still":[403],"median":[408],"exposure":[409],"wks.":[412],"Clinical":[413],"information:":[415],"NCT01243944.":[416]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-04-07T00:00:00"}